Clinical Trials Browser

Phase 3 × OTHER × Medroxyprogesterone × Clear all

NCT00416429 2012-09-26

Medroxyprogesterone or Interferon and/or Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Phase 3 Completed

Carcinoma, Renal Cell, Kidney Neoplasms